Following the establishment of the European Union reference laboratory for Rift Valley fever, and in accordance with Article 93(2), point (a), of Regulation (EU) 2017/625, the Commission followed a public selection process for the designation of the European Union reference laboratory for Rift Valley fever.
Recital 2, Regulation (EU) 2022/2304
In forcesince 24 Nov 2022